Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study

BACKGROUND: In September 2009, a live attenuated herpes zoster vaccine (ZVL) became available in Canada. Beginning in September 2016, ZVL was made available to all Ontario residents aged 65–70 through a publicly funded immunization program. We assessed the impact of ZVL availability and its subseque...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Infect Dis
Auteurs principaux: Martins, Diana, McCormack, Daniel, Tadrous, Mina, Gomes, Tara, Kwong, Jeffrey C, Mamdani, Muhammad M, Buchan, Sarah A, Antoniou, Tony
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Major Articles and Commentaries
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7840108/
https://ncbi.nlm.nih.gov/pubmed/31922540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa014
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires